These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16511398)

  • 1. Transmission of human immunodeficiency virus type 1 nevirapine resistance mutation K103N from a treatment-naive mother to her child.
    Schmitz T; Kleinkauf N; Klempa B; Ringe H; Varnholt V; Grosch-Wörner I
    Pediatr Infect Dis J; 2006 Mar; 25(3):275-6. PubMed ID: 16511398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 drug resistance and mother-to-child transmission.
    Morris L; Pillay C; Gray G; McIntyre J
    SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients.
    Hachiya A; Gatanaga H; Kodama E; Ikeuchi M; Matsuoka M; Harada S; Mitsuya H; Kimura S; Oka S
    Virology; 2004 Oct; 327(2):215-24. PubMed ID: 15351209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades.
    Palumbo P; Holland B; Dobbs T; Pau CP; Luo CC; Abrams EJ; Nesheim S; Vink P; Respess R; Bulterys M;
    J Infect Dis; 2001 Nov; 184(9):1120-6. PubMed ID: 11598834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
    Simpore J; Pietra V; Pignatelli S; Karou D; Nadembega WM; Ilboudo D; Ceccherini-Silberstein F; Ghilat-Avoid-Belem WN; Bellocchi MC; Saleri N; Sanou MJ; Ouedraogo CM; Nikiema JB; Colizzi V; Perno CP; Castelli F; Musumeci S
    J Med Virol; 2007 Jul; 79(7):873-9. PubMed ID: 17516517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
    van Zyl GU; Claassen M; Engelbrecht S; Laten JD; Cotton MF; Theron GB; Preiser W
    J Med Virol; 2008 Jun; 80(6):942-6. PubMed ID: 18428139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
    Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
    Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.
    Vignoles M; Barboni G; Agosti MR; Quarleri J; García MK; Ayala SG; Salomón H
    Antivir Ther; 2009; 14(8):1175-81. PubMed ID: 20032547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.
    Parham L; de Rivera IL; Murillo W; Naver L; Largaespada N; Albert J; Karlsson AC
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1055-9. PubMed ID: 21417948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
    Han J; Wang L; Jiang Y; Zhang Q; Fang L; Yao J; Wang Q
    Int J STD AIDS; 2009 Apr; 20(4):249-54. PubMed ID: 19304969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.
    Johnson JA; Li JF; Morris L; Martinson N; Gray G; McIntyre J; Heneine W
    J Infect Dis; 2005 Jul; 192(1):16-23. PubMed ID: 15942889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vertical transmission of multidrug-resistant Q151M human immunodeficiency virus type 1 strains.
    Henry M; Thuret I; Solas C; Genot S; Colson P; Tamalet C
    Pediatr Infect Dis J; 2008 Mar; 27(3):278-80. PubMed ID: 18277921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
    Pilger D; Hauser A; Kuecherer C; Mugenyi K; Kabasinguzi R; Somogyi S; Harms G; Kunz A
    Antivir Ther; 2011; 16(1):109-13. PubMed ID: 21311114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.
    Jacob MS; Durairaj A; Vijayakumari J; Srijayanth P; Sivakumar MR
    Indian J Pathol Microbiol; 2011; 54(2):359-61. PubMed ID: 21623090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire.
    Chaix ML; Ekouevi DK; Rouet F; Tonwe-Gold B; Viho I; Bequet L; Peytavin G; Toure H; Menan H; Leroy V; Dabis F; Rouzioux C;
    J Infect Dis; 2006 Feb; 193(4):482-7. PubMed ID: 16425126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.
    Cunningham CK; Chaix ML; Rekacewicz C; Britto P; Rouzioux C; Gelber RD; Dorenbaum A; Delfraissy JF; Bazin B; Mofenson L; Sullivan JL
    J Infect Dis; 2002 Jul; 186(2):181-8. PubMed ID: 12134253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant.
    Johnson VA; Petropoulos CJ; Woods CR; Hazelwood JD; Parkin NT; Hamilton CD; Fiscus SA
    J Infect Dis; 2001 Jun; 183(11):1688-93. PubMed ID: 11343221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.
    Martinson NA; Morris L; Johnson J; Gray GE; Pillay V; Ledwaba J; Dhlamini P; Cohen S; Puren A; Steyn J; Heneine W; McIntyre JA
    AIDS; 2009 Apr; 23(7):809-16. PubMed ID: 19287298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
    Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.